Histamine 2 receptor antagonists do not improve the outcomes of hospitalized COVID-19 patients
Saved in:
| Main Authors: | Waseem Amjad, Faisal Kamal, Adnan Malik, Ritu Singh, Sultan Mahmood |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2021-07-01
|
| Series: | Gastroenterology Review |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Histamine-2-receptor-antagonists-do-not-improve-the-outcomes-of-hospitalized-COVID-19-patients,41,44707,1,1.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acid Suppressive Drugs
by: Cheol Min Shin
Published: (2022-06-01) -
Role of Gastric Acid Suppression Therapy in Erosive Esophagitis: From H2 Receptor Antagonists, Proton Pump Inhibitors, to Potassium-Competitive Acid Blockers
by: Ryan Herardi, et al.
Published: (2025-07-01) -
Accelerated risk of renal disease progression in pre-ESRD patients with proton pump inhibitors use: a nationwide population-based study
by: Chien-Huei Huang, et al.
Published: (2024-12-01) -
Predictive Value of Individual Gastric Secretion Indices and Their Constellations for Predicting the Response of Gastric Mucosal Parietal Cells to Pentagastrin Stimulation and Famotidine Blocking Effect in Patients with Gastric and Duodenal Ulcers
by: M. Pliatsko, et al.
Published: (2025-03-01) -
Optimal Use of Proton Pump Inhibitors and Potassium-competitive Acid Blockers
by: Jong Kyu Park
Published: (2023-09-01)